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The optimal treatment of schizophrenia patients requires integration of medical and 
psychosocial inputs. In Germany, various health-care service providers and institutions 
are involved in the treatment process. Early and continuous treatment is important but 
often not possible because of the fragmented medical care system in Germany. The 
Integrated Care Initiative Schizophrenia has implemented a networked care concept 
in the German federal state of Lower Saxony that integrates various stakeholders of 
the health care system. In this initiative, office-based psychiatrists, specialized nursing 
staff, psychologists, social workers, hospitals, psychiatric institutional outpatient’s 
departments, and other community-based mental health services work together in an 
interdisciplinary approach. Much emphasis is placed on psychoeducation. Additional 
efforts cover socio-therapy, visiting care, and family support. During the period from 
October 2010 (start of the initiative) to December 2012, first experiences and results of 
quality indicators were collected of 713 registered patients and summarized in a quality 
monitoring report. In addition, standardized patient interviews were conducted, and 
duration of hospital days was recorded in 2013. By the end of 2012, patients had been 
enrolled for an average of 18.7 months. The overall patient satisfaction measured in a 
patient survey in June 2013 was high and the duration of hospital days measured in a 
pre–post analysis in July 2013 was reduced by 44%. Two years earlier than planned, the 
insurance fund will continue the successfully implemented Integrated Care Initiative and 
adopt it in the regular care setting. This initiative can serve as a learning case for how to 
set up and measure integrated care systems that may improve outcomes for patients 
suffering from schizophrenia.
Keywords: schizophrenia, integrated care, patient-centered, quality indicators, duration of hospital stays, 
psychoeducation, outpatient health care services
inTrODUcTiOn
Schizophrenia is a mental disorder that affects ~0.3–0.7% of people at some point in their lives (1). 
The chronic and disabling course of the illness may have a major impact on daily routine, quality 
of life, and life planning. Thus, patients need intensive and long-term support in order to be able to 
cope with everyday life and to lead a life as close to normal as possible.
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The optimal treatment of schizophrenia patients requires inte-
gration of medical and psychosocial inputs and has to be tailored 
to the individual needs of the patients and their families. The 
patient-centered care should be provided in an outpatient setting 
by a multidisciplinary team and should comprise medical, social, 
psychological, and psychotherapeutic support (2). In Germany, 
various health-care service providers and institutions are involved 
in the process of treatment of schizophrenia. However, continuous 
treatment is often not possible because of the fragmented medi-
cal care system in Germany (e.g., no short-term appointments 
with the physician who is to provide continued treatment after 
discharge from hospital or no outpatient medical contact if a 
crisis situation sets in the evening or during the weekend) (3). To 
overcome these difficulties, patient outcome-oriented solutions 
are needed that follow an intensified, integrative approach that 
exceeds the provided standard care in Germany. We hypothesized 
that this implies the coordination of treatment options offered by 
different service providers to increase therapy efficiency.
about the integrated care initiative 
schizophrenia
After a tender procedure, in July 2010 AOK Lower Saxony, the 
largest statutory sick fund in Lower Saxony, closed a contract on 
integrated care for schizophrenia sufferers with the Institute for 
Innovation and Integration in Healthcare (I3G GmbH), accord-
ing to § 140 b Abs. 1 SGV V (German law on social welfare). The 
I3G is an independent subsidiary of the researching pharmaceuti-
cal company Janssen-Cilag GmbH. I3G bore the responsibility for 
the process and budget, as well as the economic risk. I3G assigned 
parts of the on-site operative implementation to the company 
Care4S GmbH. Their task was to locally build, expand, and sup-
port networks with the Integrated Care parties involved – taking 
up on existing structures wherever possible.
In addition, an independent multidisciplinary expert commit-
tee, composed of key stakeholders involved in schizophrenia care, 
such as medical specialists from hospitals and practices, experts 
in the areas of health care and health care research, specialist 
nurses, and relatives’ representatives, was established. The expert 
committee gave advice on the implementation, advancement, and 
evaluation.
Objectives and strategy of the integrated 
care initiative schizophrenia
The Integrated Care Initiative Schizophrenia pursued the goal 
of optimizing patient-centered care for patients suffering from 
schizophrenia. The initiative is based on a networked care con-
cept that integrates various stakeholders of the health care system. 
Medical attention is closely linked to psychosocial support in this 
network. Office-based psychiatrists, specialized nursing staff, 
psychologists, social workers/pedagogues, hospitals, psychiatric 
institutional outpatient’s departments, and other community-
based mental health services collaborate in an interdisciplinary 
approach.
In this initiative, local specialized physicians and psychiatric 
care services organize the outpatient treatment. However, supera-
bundance and shortage of medical care are both to be avoided. 
A focus is on assisting the patients in coping with their illness in 
their domestic surroundings whenever possible (e.g., by home 
treatment). This requires close cooperation between all care 
providers across professional groups and institutions.
Apart from establishing and improving networks, this initia-
tive gives patients access to an augmented range of ambulatory 
treatment options that are not offered or not offered to that extent 
in standard care in Germany. While the drug treatment options 
are the same as in standard care, this initiative has much more 
psychosocial care options. Much emphasis is placed on psychoe-
ducation. Further efforts cover the areas of socio-therapy, visiting 
care, and family support. As an example, specialist nursing is 
available for all patients according to the needs of the patient. 
Home treatment is provided by psychiatric nurses directed by an 
office-based psychiatrist. In case of hospitalization, cooperation 
with clinicians is intended to ensure that inpatient treatment can 
be evolved into intensive outpatient treatment. Here, an expert 
team supports the patient. Furthermore, a 24/7 crisis service is 
available for patients and their families.
The pivotal contact for the patients is the psychiatrist – he or 
she is in charge of the therapy. The psychiatrists are independent 
in their patient-oriented therapeutic decision making, as well 
as being committed to the current status of understanding in 
medical science. Therapy decisions comprise all drugs that are 
approved and available in the German market for the treatment 
of schizophrenia. Together with the other members of the care 
team, but above all in consultation with the patient (“shared 
decision-making”), the psychiatrist defines therapy modules 
meeting the patient’s needs. These modules correspond to the 
latest scientific insights by the WHO and DGPPN (German 
Society of Psychiatry, Psychotherapy and Neurology). They form 
the multilevel and modular treatment path of the Integrated 
Care Initiative Schizophrenia, which shall allow tailoring care to 
patients’ needs and personal preferences (Figure 1).
Here, we present the first experiences and results of descrip-
tive analyses from the quality monitoring report of the Integrated 
Care Initiative Schizophrenia Lower Saxony during the period 
from October 2010 (start of the initiative) to December 2012.
MaTerials anD MeThODs
Participation in the Integrated Care Initiative was open for AOK 
insurees above 18 years of age with registered residence in Lower 
Saxony according to their health insurance card upon presenta-
tion of a confirmed diagnosis of schizophrenia (ICD-10: F20, cor-
relating with the international statistic classification of diseases 
and related health problems, version 2010). The participation was 
voluntary. The patient had to contact a psychiatrist who was a 
contract partner of the Integrated Care Initiative, then he was 
informed about the integrated care provision and had to sign a 
declaration of participation. There were no exclusions regarding 
schizophrenia severity, comorbidities, or previous hospitaliza-
tions. In order to meet data privacy requirements, a system for 
data transfer was implemented.
The Integrated Care Initiative was implemented by office-based 
psychiatrists in cooperation with specialized psychiatric nursing 
staff. They introduced the patients to the various care services 
FigUre 1 | Patient-centered approach in the integrated care initiative schizophrenia.
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and types of support. Psychoeducational groups for patients and 
their family members were set up by the network partner, aiming 
at improving knowledge about the disease, which in turn enables 
improved compliance and early detection of relapses (4).
Routine records from the Integrated Care Initiative and 
accounting data of the AOK Lower Saxony as well as qualitative 
and quantitative effects of care recorded in an IT-documentation 
system served as basis for the descriptive analyses.
educational Materials and Training 
concept
The Integrated Care Initiative provided a range of materials and 
documents specifically developed for conducting outpatient 
psychoeducation. The standardized training followed the APES 
manual (Arbeitsbuch PsychoEdukation bei Schizophrenie, 
published by Schattauer Verlag) and could be supplemented with 
further contents as needed.
An initiative coordinator organized workshops that provide 
the network partners with strategies for the implementation of 
psychoeducation in the individual regions. In these train-the-
trainer sessions, local specialists and the outpatient psychiatric 
care team were educated in the theory and practice of psychoe-
ducation based on the APES manual. Among others, the content 
addressed the symptoms and course of the disease, stress coping 
models, issues of salutogenesis and empowerment, early warning 
symptoms, and crisis management. Participants were qualified to 
conduct future psychoeducation as trainers.
The workshops on how to conduct psychoeducation took 
place in 1-day blocks. Didactics of knowledge transfer, visualiza-
tion methods, and interactive conversation were central learn-
ing units. Role-playing exercises consolidated the theoretical 
knowledge.
Quality indicators
When establishing a new form of health care, it is essential to 
verifiably ensure and transparently document the quality of 
care. In contrast to the somatic area, in the psychiatric field 
quality indicators are not standard practice in Germany yet. 
The subjective perception of disease and concomitant personal 
assessment of the treatment results make valid and reliable quality 
measurement based on objective criteria an extremely challeng-
ing task. To face this challenge, in 2009, the Federal Association 
of the AOK initiated a project to develop quality indicators for 
patient-centered care of people affected by schizophrenia (5). 
The following indicators derived from this are aimed not simply 
at individual care areas, but rather at an integrated cross-sector 
treatment approach. They were used to monitor the status quo of 
the initiative:
 (A) Continuity of outpatient treatment after discharge from 
hospital: the percentage of patients who received further 
outpatient treatment within 7 days after being discharged.
 (B) Hospital readmission rate: the percentage of patients who 
were readmitted to hospital within 30 days after an inpatient 
psychiatric treatment.
 (C) Antipsychotic polypharmacy: the number of patients who 
took at least two antipsychotics simultaneously over a times-
pan of at least 4 weeks during the reference period.
 (D) Compulsory treatment: this indicator describes how many 
patients in the Integrated Care Initiative Schizophrenia were 
hospitalized due to legal requirements.
 (E) Discontinuation of treatment for more than 90  days: the 
percentage of patients who had no contact with health care 
providers within the Integrated Care Initiative Schizophrenia 
for more than 90 days.
 (F) Case management: the percentage of severely ill patients 
[defined by a global assessment of functioning (GAF) scale 
value below 50] who were in contact with a case manager 
during the last 6 months of the reference period.
 (G) Inclusion of relatives into the treatment: the proportion of 
patients whose relatives were included in the treatment sup-
port during the reference period.
 (H) Availability of a disease self-education program: the propor-
tion of patients who participated in psychoeducational 
training during the reference period.
 (I) Number of suicides and suicide attempts: all documented 
suicides and suicide attempts per 1,000 patients.
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Patient satisfaction
In addition to analysis of the quality indicators, qualitative and 
quantitative effects of care from the patients’ points of view were 
recorded. In 2013, patients were retrospectively interviewed 
concerning their experience with this initiative. The patient 
interviews were conducted from May 1 to June 15, 2013 using 
a standardized eight-item questionnaire (modified ZUF-8) 
(6). Every answer was graded from 1 (lowest satisfaction) to 4 
(highest satisfaction). Scores from all of the eight answers on the 
patient questionnaire were summed up to form an overall rating 
so that 32 was the highest rating and 8 was the lowest rating for 
minimum participant satisfaction.1
Duration of hospital stays
The time that patients spent in the hospital was routinely 
monitored in the quality assurance review. All patients who 
participated in the Integrated Care Initiative for more than a year 
were included into a pre–post analysis of this parameter in July 
2013, regardless of schizophrenia severity. The analysis compared 
the total number of days spent in hospital during the year before 
enrollment with the total number of days spent in hospital within 
the first year after enrollment.
resUlTs
By the end of 2012, 713 out of ~6,800 eligible patients were enrolled 
in the regions where the program was activated. The observed 
patient group (N = 713) consisted of 51% male patients and 49% 
female patients. The mean ages in the male and female group were 
44.2 (±12.2) years and 50.3 (±12.0) years, respectively.
By the end of 2012, patients were enrolled in the Integrated 
Care Initiative for an average of 18.7 months. Ninety-five out of 
713 patients (13.0%) had at least one hospitalization.
Data on comorbidities were available from 499 patients who 
participated during the period from July 2011 to June 2012. In all, 
51.0 and 85.0% of the patients were diagnosed with at least one 
secondary psychiatric disease and at least one somatic disorder, 
respectively. This correlates with other epidemiological data 
obtained for Germany (7, 8).
Quality indicators
Continuity of Outpatient Treatment after Discharge 
from Hospital
More than half of the hospitalized patients (57.5%) received 
further outpatient treatment timely, i.e., within 7 days after being 
discharged.
Hospital Readmission Rate
In the Integrated Care Initiative Schizophrenia, a total of 18.4% of 
patients were readmitted to hospital within 30 days after discharge 
from an inpatient psychiatric treatment. International literature 
reports readmission rates between 20.7 and 34.5% (9).
1 One patient did not answer question 6 of the ZUF-8 questionnaire (N for question 
6 = 120).
Antipsychotic Polypharmacy
In the Integrated Care Initiative Schizophrenia, 21.6% of patients 
received two or more different antipsychotics for at least 28 days. 
By comparison, international literature reports 40.0% of patients 
with antipsychotic polypharmacy (10, 11).
Compulsory Treatment
Out of 95 patients who had a temporary stay at an inpatient facil-
ity, 6.3% experienced compulsory treatment.
Discontinuation of Treatment for over 90 Days
In the Integrated Care Initiative Schizophrenia, 15.0% of patients 
had no contact to a key carer for at least 90 days. Weinmann et al. 
give a reference value of 15.0% for this indicator (5).
Case Management
As no rating by GAF value was available, the analysis included 
not only severely ill persons but all the patients enrolled in the 
reference period.
In the Integrated Care Initiative Schizophrenia, 80.0% of the 
patients were individually looked after by the key carer system. 
International literature reports values between 38.0 (12) and 
65.0% (severely ill patients) (13).
Inclusion of Relatives into the Treatment
In the Integrated Care Initiative Schizophrenia, the percentage of 
patients whose relatives were included into the treatment support 
was 17.1% (14).
Availability of a Disease Self-Education Program
By the end of 2012, 2.7% of the patients in the Integrated Care 
Initiative Schizophrenia participated in outpatient psychoeduca-
tional training. Since the launch of the initiative in autumn 2010, 
the model was tested in pilot regions in Lower Saxony until the 
first quarter of 2012. The rollout in Lower Saxony was started 
in April 2012. Thus, the analysis of 2012 data included only the 
startphase of outpatient psychoeducation, which was in the phase 
of implementation.
One of the first (October 2010) activated regions within the 
Integrated Care Initiative was Hildesheim in Lower Saxony. In 
this area, 8.6% of the enrolled patients took part in psychoeduca-
tional trainings by the end of 2012.
Number of Suicides and Suicide Attempts
As per Hor et  al., the suicide rate (life-time risk) among 
schizophrenia patients is about 5.0% (15). In the Integrated Care 
Initiative Schizophrenia, the documented suicide rate amounted 
to 0.4% during the year 2012.
Patient satisfaction
A total of 344 patients could be identified who were registered 
after the start of the initiative in October 2010 and participated 
for at least 12 months. After a period of 1 year, patients can be 
expected to be fully integrated in the integrated care program and 
therefore be able to give a valid rating. In June 2013, 121 of the 344 
patients (males: 67 and females: 54) from 25 specialist practices 
TaBle 1 | Patient responses to the eight items of the modified ZUF-8 questionnaire.
item Question response, N = 121; patients (%)
1 Please rate the quality of the care you have received Very good Good Fair Poor
35% 62% 1% 2%
2 Has the treatment that you have received met your expectations? Clearly yes Generally yes Rather not Clearly not
46% 48% 3% 3%
3 To what extent did the treatment by the physician/specialist nurse 
service fulfill your needs?
Almost completely By and large Only partially Not at all
51% 44% 5% 0%
4 Would you recommend Integrated Care to a friend if he/she 
needed similar help?
Clearly yes Probably yes Probably not Clearly not
65% 26% 6% 3%
5 Please rate your satisfaction with the level of help you received 
from the physician/specialist nurse service within Integrated Care
Very satisfied Satisfied Somewhat satisfied Dissatisfied
50% 47% 3% 0%
6 Did the care by the physician and/or specialist nurse service help 
you to cope with your problems better?*
Yes, helped a lot Yes, helped a little No, did not help No, has made things worse
66% 29% 4% 0%
7 Please rate your general satisfaction with the integrated care you 
have received
Very satisfied Satisfied Somewhat satisfied Dissatisfied
55% 43% 2% 0%
8 Will you continue your treatment within Integrated Care? Definitely Probably Probably not Definitely not
71% 26% 2% 1%
*One patient did not answer question 6 of the ZUF-8 questionnaire (N for question 6 = 120).
FigUre 2 | age and gender distribution of the 121 patients who 
completed the modified ZUF-8 questionnaire.
FigUre 3 | Pre/post analysis of days in hospital due to an icD-10-cM 
F20 diagnosis (N = 458; July 2013).
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took part in interviews. At the time of the survey, the participat-
ing patients were enrolled in the initiative on average for almost 
2 years (23.9 ± 5.5 months) and had a mean age of 47 (±12) years. 
Figure 2 shows the gender-specific age pattern of this population.
The findings from the interview analyses showed high patient 
satisfaction scores for each of the eight items of the questionnaire 
(Table 1). The mean total score was 27.9 (±3.2) out of a maximum 
of 32 points achievable.
Duration of hospital stay
Of the 713 patients enrolled in the Integrated Care Schizophrenia 
at the end of 2012, 13.3% were treated in hospital. On average, the 
length of hospital stays for all enrolled patients was 5.6 days. In 
comparison, the accumulated length of stay in 2011 for all schizo-
phrenia patients insured by AOK Lower Saxony was 11 days.
This positive trend was confirmed by a pre–post analysis 
performed in 2013, which compared the sum of days spent in 
hospital in the year before and the year after enrollment in the 
Integrated Care Schizophrenia. Statistical analysis was performed 
in July 2013 and evaluated the data of 458 patients. The quality 
monitoring covered an observation period of about 2 years for 
the entire group.
In the year before enrolling in this initiative, the patients 
spent a total of 6,977 days in hospital due to schizophrenia (F20 
diagnosis). During the first year of enrollment, they spent a 
total of 3,906  days in hospital due to an F20 diagnosis. This 
means a reduction of 44.0% in the number of inpatient days 
during the Integrated Care Schizophrenia reference period 
(Figure 3).
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DiscUssiOn
Today, the routine care setting of mental ill patients remains frag-
mented (3). By offering more patient-centered care, the patient 
outcomes regarding primary, secondary, and health system 
parameters can be improved (16).
The special role of Psychoeducation in 
schizophrenia
In our opinion, a key driver was the actual implementation of psy-
choeducation. The Integrated Care network partners often report 
that the biggest obstacle is motivating the patients to participate. 
However, in our experience, once the patients are convinced 
and take part, they are enthusiastic about the psychoeducational 
spectrum.
Psychoeducation is defined as systematic, structured, and 
didactic provision of information on the disorder and its treat-
ment. This educational method allows the afflicted and their 
relatives to obtain information about schizophrenia, to receive 
support with coping strategies, and thus to be empowered to 
make informed decisions concerning relapse prevention (17). 
There is a body of evidence supporting the fact that psychoeduca-
tion of patients with schizophrenia improves understanding of 
mental illness, increases quality of life, enhances compliance with 
antipsychotics, and can reduce relapse rates (17, 18). National and 
international guidelines classify the psychoeducation as a highly 
effective intervention in order to reduce hospital readmission 
rates, the resultant costs, and substantial human suffering (17).
Clinical practice shows, however, that there still exists an 
enormous gap between scientific findings and clinical reality. 
Although the benefit of psychoeducation for the empowerment 
of patients and the effectiveness of the therapy are proven, to date, 
it is provided only for every fifth inpatient with schizophrenia 
and only for one family member of every 50th patient (17). In 
the outpatient sector, psychoeducation is barely part of standard 
care so far. It therefore seems to be essential to offer structured 
psychoeducation for more patients with schizophrenia and their 
families than is the case today.
In the Integrated Care Initiative, the network partner himself 
or herself organized the training for the patients. This may be 
of importance because the patients confided in their caregiver. 
This mutual trust was essential in convincing the patients to 
participate.
The integrated care initiative as a 
learning case
Since the initiative started, the Integrated Care Initiative continu-
ously developed new regions in the federal state of Lower Saxony, 
and, from the beginning of 2013, is now available area-wide. The 
first experiences with the Integrated Care Initiative in a federal state 
of Germany are encouraging. The introduction of the initiative 
improved communication between all carers. As a consequence, 
patients benefited from shorter waiting times, reduced bureau-
cracy, shorter distances, and an unchanging point of contact. The 
closer integration of relatives into the initiative may additionally 
help to better manage crisis situations. Correspondingly, patient 
interviews showed high patient satisfaction with the treatment 
path selected by the initiative.
This concept paves a way for optimizing health-care systems. 
Efforts and strengths of all participants who are involved in patient 
care could be joined successfully beyond existing structures. 
Linking and integrating of all the participants in the health-care 
system, including health-care providers, funding bodies, and 
health-care industry, may further improve quality of care in a 
sustainable manner. A health care company, in particular, can 
make essential contributions to achieving this goal by participat-
ing in the development and implementation of comprehensive 
solutions, as shown in the present Integrated Care Initiative.
Two years earlier than planned, the AOK continued the suc-
cessfully implemented Integrated Care Initiative and adopted 
it in the regular care setting starting from January 2015. The 
AOK carried on ensuring optimum treatment for the insurees. 
The established procedures for participating physicians and 
psychiatric nursing services remained in place. Parallel to this, 
the pharmaceutical company Janssen continues to work on opti-
mizing modular health-care concepts to increase outcomes for 
patients who are suffering from mental health disorders.
limitations and Outlook
It is important to note that the present paper is not a research study 
but a quality monitoring report of a novel care setting initiative. 
Quality monitoring of health-care performance is mandatory in 
the German health system (§ 140 b Abs. 1 SGV V – German law 
on social welfare).The data presented here were collected in the 
framework of the quality assurance of the integrated care project.
An evaluation designed as a prospective, observational cohort 
study with two independent control groups was originally 
planned but could not be finalized by the independent contractor 
due to minor recruitment numbers.
In our view, the Integrated Care Initiative can serve as a learn-
ing case for how to set up and measure integrated care systems 
that may improve outcomes for schizophrenic patients. Such 
real-world quality monitoring data are as yet rare and can make 
an important contribution to reflection on appropriate ways to 
optimize patient health-care services for mental health reasons. 
A further evaluation of routine data is ongoing to determine 
how the findings of the initiatives’ quality monitoring report will 
develop compared against standard care.
eThics
Please note: This is not a research study but a quality monitoring 
report of a novel care setting initiative. Quality monitoring of 
health-care performance is mandatory according to the German 
Law. The data were collected in the framework of the quality 
assurance of the integrated care project. Those data are rare and 
are often seen as an important real-life contribution to the mental 
health-care issue. An evaluation designed as a prospective, obser-
vational cohort study with two independent control groups was 
originally planned but could not be finalized by the independent 
contractor due to minor recruitment numbers. Further routine 
data analyses will compare the integrated care schizophrenia 
against standard care.
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